Thanks Debbie
I agree about insuline problem and indeed Diabetics have an increase incidence of cancer
http://www.ncbi.nlm.nih.gov/sites/en...=pubmed_docsum
. But here I am presuming no insuline problem. Although we refer to blood sugar there are various type of sugar in the blood and in fact these can varie quite a bit in fact in range 70 to 150mg/dL and that is the normal range! and secondly yes we are all different and more importantly our cancer cells are different we each of us have cells that have mutated in one way or another with some commun features such as Her2. I never said that fasting is useful 100% of the time, nothing is as we know.
Anyhow I will finish with this post but hopefully will let some pounder on the following
http://www.ncbi.nlm.nih.gov/sites/en...=pubmed_DocSum
study in 1985
Three groups of BALB/C mice were injected with an aggressive mammary tumor and placed on three dietary regimens designed to produce three different glycemic levels. Mortalities 70 days after injection were 16 of 24 hyperglycemic mice, 8 of 24 normoglycemic, and 1 of 20 hypoglycemic (chi-square p less than .005). Taken together with other experiments and human data discussed briefly, this result suggests that glycemic modulation of tumor tolerance should be evaluated in human trials.
They never were any follow up.. there are no money to be made in fasting.
However I am looking forward to the result of the current study (mention above) which is putting people on a high fat low carb diet (ketogenic diet) and measuring the size of their tumours with PET scan after 4 weeks. If there is no basis in what I said I would be grateful for someone to explain why they would have such a clinical trial?
__________________

35 y/o
June 06: BC stage I
Grade 3; ER/PR neg
Her-2+++; lumpectomies
Aug 06: Stage IV
liver mets: 6 tumours
July 06 to Jan 07: 2*FEC+6*Taxotere; 3*TACE; LITT
March 07- Sept 07: Vaccination trial (phase 2, peptide based) at the UW (Seattle).
Herceptin since 2006
NED til Oct 09
Recurrence Oct 2009:
to internal mammary gland since October 2009 missed on Oct and March 2010 scan.. palpable nodes in May 2010 when I realised..
Nov 2011:7 mets to lungs progressing fast failed hercp/tykerb/xeloda combo..
superior vena cava blocked: stent but face remains puffy
April 2012: Teresa Trial, randomised to TDM1
Nov 2012 progressing on TDM1
Dec 2012 blockage of my airways by tumours, obliteration of these blocking tumours breathing better but hoping for more- at mo too many tumours to count in the lungs and nodes.
Dec 2012 Starting new trial S-222611 phase 1b dual egfr her2+ inhibitor.
'Under no circumstances should you lose hope..' Dalai Lama